Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18658011 | HYDROGEL MEDIUM FOR THE STORAGE AND PRESERVATION OF TISSUE | May 2024 | April 2025 | Allow | 11 | 0 | 1 | No | No |
| 18583237 | HUMAN NASAL TURBINATE-DERIVED MESENCHYMAL STEM CELL-BASED, 3D BIOPRINTED CONSTRUCT, AND USE THEREOF | February 2024 | June 2025 | Allow | 16 | 1 | 0 | No | No |
| 18490248 | Triple Negative Breast Cancer Treatment Method | October 2023 | May 2025 | Abandon | 19 | 1 | 1 | No | No |
| 18163321 | GLUCONIC ACID DERIVATIVES FOR USE IN THE TREATMENT AND/OR PREVENTION OF MICROBIAL INFECTIONS | February 2023 | October 2024 | Allow | 20 | 2 | 1 | Yes | No |
| 17977302 | GUMMY COMPOSITION AND METHODS OF USE THEREOF | October 2022 | November 2024 | Abandon | 24 | 1 | 1 | No | No |
| 17893859 | SCAFFOLD WOUND DRESSING | August 2022 | January 2023 | Allow | 5 | 1 | 0 | No | No |
| 17669768 | AGROCHEMICAL COMPOSITION | February 2022 | June 2024 | Allow | 28 | 5 | 0 | Yes | No |
| 17634009 | AN AGROCHEMICAL COMPOSITION | February 2022 | April 2025 | Allow | 38 | 1 | 1 | Yes | No |
| 17595217 | Microcapsule With A Porous Or Hollow Core And A Shell Containing A Component Releasing Gas Upon Contact With An Acid | November 2021 | April 2025 | Abandon | 41 | 1 | 1 | Yes | No |
| 17391026 | Nonhormonal Unisex Contraceptives | August 2021 | June 2024 | Abandon | 34 | 1 | 1 | No | No |
| 17371562 | MODULAR PLANTING MATERIAL FOR NATURAL TURF IN SPORTS FIELD AND ITS MANUFACTURING PROCESS | July 2021 | February 2025 | Abandon | 43 | 0 | 1 | No | No |
| 17311706 | COMPOSITIONS COMPRISING FLORPYRAUXIFEN THAT SAFEN WHITE CLOVER AND METHODS OF USE THEREOF | June 2021 | September 2024 | Abandon | 40 | 0 | 1 | No | No |
| 17335542 | CUCURBITURIL MOLECULAR CONTAINERS AND METHODS OF USING SAME | June 2021 | January 2025 | Abandon | 43 | 2 | 1 | No | No |
| 17298053 | COMPOSITION FOR ENHANCING DROUGHT AND OSMOTIC STRESS RESISTANCE, AND THEIR USES | May 2021 | June 2025 | Abandon | 49 | 3 | 1 | No | No |
| 17296330 | Immune Supplement Composition | May 2021 | June 2025 | Abandon | 49 | 3 | 1 | No | No |
| 17291267 | COMPOSITIONS COMPRISING PYRIDINE CARBOXYLATE HERBICIDES AND CELLULOSE BIOSYNTHESIS INHIBITOR HERBICIDES | May 2021 | October 2024 | Abandon | 41 | 0 | 1 | No | No |
| 17291239 | COMPOSITIONS COMPRISING PYRIDINE CARBOXYLATE HERBICIDES AND FATTY ACID AND LIPID SYNTHESIS INHIBITOR HERBICIDES | May 2021 | October 2024 | Abandon | 41 | 0 | 1 | No | No |
| 17285833 | NANOEMULSION CANNABIS FORMULATIONS AND METHODS OF MAKING SAME | April 2021 | August 2024 | Abandon | 40 | 0 | 1 | No | No |
| 17220073 | COMPOSITIONS AND METHODS FOR TREATING MYELOFIBROSIS | April 2021 | October 2023 | Abandon | 30 | 4 | 1 | Yes | No |
| 17281005 | WOOD PRESERVATIVES | March 2021 | June 2025 | Allow | 50 | 2 | 1 | No | No |
| 17213986 | ANTI-ALLERGENIC OCULAR COMPOSITIONS AND EYELID CLEANSING WIPES | March 2021 | October 2024 | Abandon | 43 | 1 | 1 | No | No |
| 17277219 | HERBICIDALLY ACTIVE SUBSTITUTED PHENYLPYRIMIDINE HYDRAZIDES | March 2021 | November 2024 | Abandon | 44 | 0 | 1 | No | No |
| 17176726 | Galectin-3 Governs and Coordinates ESCRT and Autophagic Responses During Endomembrane Damage | February 2021 | October 2023 | Abandon | 32 | 1 | 1 | No | No |
| 17121558 | N-Phenylacetyl-L-prolylglycine ethyl ester compositions and methods for using the same | December 2020 | February 2023 | Abandon | 26 | 0 | 1 | No | No |
| 17102257 | SCAFFOLD WOUND DRESSING | November 2020 | March 2022 | Allow | 16 | 3 | 1 | Yes | No |
| 17048234 | ANTIFIBROTIC COMPOSITION | October 2020 | November 2024 | Abandon | 49 | 3 | 1 | No | No |
| 17031889 | BIOAVAILABLE MINERALS FOR THE MITIGATION OF PATHOGENS IN PLANTS | September 2020 | June 2023 | Abandon | 32 | 0 | 1 | No | No |
| 16958436 | COMPOSITION COMPRISING FERROUS SULPHATE MONOHYDRATE AND LONG CHAIN POLYUNSATURATED FATTY ACIDS | June 2020 | March 2024 | Abandon | 45 | 4 | 0 | Yes | No |
| 16771033 | Improved Method for Removing Bacterial Biofilms and Treating Tissue | June 2020 | July 2022 | Abandon | 25 | 1 | 1 | No | No |
| 16865529 | COMPOSITIONS COMPRISING SULFORAPHANE OR A SULFORAPHANE PRECURSOR AND A MILK THISTLE EXTRACT OR POWDER | May 2020 | October 2021 | Allow | 18 | 1 | 1 | Yes | No |
| 16758858 | BIOCOMPATIBLE SOFT TISSUE IMPLANT | April 2020 | June 2023 | Abandon | 37 | 0 | 1 | No | No |
| 16753899 | GLUCONIC ACID DERIVATIVES FOR USE IN THE TREATMENT AND/OR PREVENTION OF MICROBIAL INFECTIONS | April 2020 | October 2022 | Allow | 31 | 2 | 1 | No | No |
| 16645989 | TETRAZOLINONE COMPOUND AND USE THEREOF | March 2020 | December 2020 | Allow | 9 | 0 | 0 | Yes | No |
| 16798380 | NOVEL PLANT ESSENTIAL OIL AND WAX FORMULATIONS FOR USE AS PESTICIDES AND PLANT BIOSTIMULANTS | February 2020 | July 2022 | Abandon | 29 | 2 | 1 | Yes | No |
| 16794870 | Herbicide Formulations and their Use | February 2020 | October 2021 | Abandon | 20 | 3 | 0 | No | No |
| 16638416 | SOLVENTS FOR AGRICULTURAL APPLICATIONS AND PESTICIDE FORMULATIONS | February 2020 | September 2021 | Abandon | 19 | 2 | 0 | No | No |
| 16638418 | SOLVENTS FOR AGRICULTURAL APPLICATIONS AND PESTICIDE FORMULATIONS | February 2020 | January 2023 | Allow | 35 | 2 | 1 | Yes | No |
| 16773734 | PHARMACEUTICAL COMPOSITION COMPRISING NON-IONIC SURFACTANTS | January 2020 | July 2022 | Allow | 30 | 1 | 1 | No | No |
| 16632846 | NANOSTRUCTURED AND BIOCOMPATIBLE BIOCATALYSTS FOR USE IN CANCER TREATMENT | January 2020 | October 2021 | Abandon | 21 | 1 | 0 | No | No |
| 16630058 | ANTIMICROBIAL MIXTURE CONTAINING 4-(3-ETHOXY-4-HYDROXYPHENYL)BUTAN-2-ONE AND AN AMMONIUM COMPOUND, AND COSMETIC COMPOSITION CONTAINING SAME | January 2020 | June 2024 | Abandon | 53 | 4 | 1 | No | Yes |
| 16626807 | FUNGICIDAL COMPOSITIONS | December 2019 | July 2023 | Abandon | 43 | 2 | 1 | Yes | No |
| 16720290 | ACTIVE INGREDIENT COMBINATIONS COMPRISING PYRIDYLETHYLBENZAMIDES AND OTHER ACTIVE INGREDIENTS | December 2019 | October 2022 | Abandon | 34 | 1 | 1 | No | No |
| 16624195 | COMPOUNDS AND COMPOSITIONS FOR EXTENDING LIFESPAN OF A SUBJECT | December 2019 | November 2022 | Abandon | 35 | 2 | 1 | No | No |
| 16624047 | 2-[[5-(TRIFLUOROMETHYL)-1,2,4-OXADIAZOL-3-YL]ARYLOXY](THIO)ACETAMIDES FOR COMBATING PHYTOPATHOGENIC FUNGI | December 2019 | May 2023 | Abandon | 41 | 0 | 1 | No | No |
| 16711616 | MICROCAPSULES COMPRISING ACTIVE INGREDIENTS AND A METAL OXIDE SHELL, A METHOD FOR THEIR PREPARATION AND USES THEREOF | December 2019 | August 2024 | Abandon | 56 | 6 | 1 | No | No |
| 16621159 | SAFENERS AND FORMULATIONS CONTAINING SAFENERS, BIOCIDES AND INOCULANTS | December 2019 | October 2022 | Abandon | 34 | 2 | 1 | No | No |
| 16700114 | AQUEOUS HERBICIDAL COMPOSITIONS AND METHODS OF USE THEREOF | December 2019 | March 2023 | Allow | 39 | 6 | 1 | No | No |
| 16690956 | HIGH CONCENTRATION PROTEIN FORMULATION | November 2019 | March 2024 | Allow | 51 | 4 | 1 | Yes | Yes |
| 16614319 | LACTONES AS SOLVENTS IN AGROCHEMICAL FORMULATIONS | November 2019 | September 2022 | Abandon | 34 | 2 | 1 | Yes | No |
| 16610100 | Use of an Acyclic Picolinamide Compound as a Fungicide for Control of Phytopathogenic Fungi in Vegetables | November 2019 | August 2024 | Abandon | 57 | 5 | 0 | Yes | No |
| 16610102 | Use of an Acyclic Picolinamide Compound as a Fungicide for Control of Phytopathogenic Fungi in Orchard, Vineyard and Plantation Crops | November 2019 | August 2024 | Abandon | 57 | 4 | 0 | Yes | Yes |
| 16669676 | COSMETIC COMPOSITION COMPRISING BIODEGRADABLE POLYMERS | October 2019 | October 2023 | Abandon | 47 | 4 | 1 | No | No |
| 16609887 | HUMAN NASAL TURBINATE-DERIVED MESENCHYMAL STEM CELL-BASED, 3D BIOPRINTED CONSTRUCT, AND USE THEREOF | October 2019 | November 2023 | Allow | 49 | 2 | 1 | Yes | No |
| 16604223 | MESOIONIC IMIDAZOPYRIDINES AS INSECTICIDES | October 2019 | October 2022 | Abandon | 36 | 0 | 1 | No | No |
| 16582688 | NOVEL PHARMACEUTICAL FORMULATIONS CONTAINING INDIRUBIN AND DERIVATIVES THEREOF AND METHODS OF MAKING AND USING THE SAME | September 2019 | November 2021 | Abandon | 25 | 0 | 1 | No | No |
| 16497269 | DROPROPIZINE IN COMBINATION WITH AMBROXOL IN THE DOSAGE FORM OF SYRUP OR TABLETS | September 2019 | April 2024 | Abandon | 55 | 4 | 1 | No | No |
| 16497089 | WOOD PRESERVATIVES | September 2019 | May 2022 | Abandon | 32 | 2 | 0 | Yes | No |
| 16568004 | COMPOSITION COMPRISING HYDROGEN GAS FOR SUPPRESSION OR PREVENTION OF CANCER METASTASIS | September 2019 | November 2024 | Abandon | 60 | 3 | 1 | No | No |
| 16561215 | Nematode Control System and Method | September 2019 | July 2021 | Abandon | 22 | 2 | 0 | No | No |
| 16555448 | ORGANIC WEED REMOVER | August 2019 | April 2024 | Abandon | 55 | 5 | 1 | No | No |
| 16555231 | SEED TREATMENT COMPOSITION AND METHOD OF USING | August 2019 | April 2024 | Abandon | 56 | 4 | 1 | No | Yes |
| 16549043 | COMPOSITIONS AND METHODS FOR TREATING MYELOFIBROSIS | August 2019 | June 2024 | Abandon | 58 | 4 | 1 | No | Yes |
| 16485256 | HYDROGEL MEDIUM FOR THE STORAGE AND PRESERVATION OF TISSUE | August 2019 | January 2024 | Allow | 53 | 2 | 1 | Yes | No |
| 16535964 | COSMETIC BASE COMPOSITIONS AND ASSOCIATED COSMETIC COMPOSITIONS | August 2019 | February 2022 | Allow | 30 | 3 | 1 | Yes | No |
| 16481606 | METHOD OF STRENGTHENING HAIR | July 2019 | October 2023 | Abandon | 51 | 5 | 0 | No | No |
| 16514586 | SECNIDAZOLE SOFT GELATIN CAPSULE AND METHODS AND USES THEREOF | July 2019 | November 2022 | Abandon | 40 | 3 | 1 | Yes | No |
| 16508626 | ANTI-ALLERGENIC OCULAR COMPOSITIONS AND EYELID CLEANSING WIPES | July 2019 | December 2020 | Allow | 17 | 1 | 1 | Yes | No |
| 16504660 | MICROSPHERICAL PARTICLE | July 2019 | March 2022 | Abandon | 32 | 2 | 0 | No | No |
| 16458086 | SUPPLEMENT PATCH | June 2019 | August 2024 | Abandon | 60 | 7 | 0 | No | No |
| 16452648 | METHOD FOR CONTROLLING SAN JOSE SCALE | June 2019 | May 2023 | Abandon | 47 | 4 | 0 | No | Yes |
| 16470426 | TOPICAL SKIN LIGHTENING ADDITIVE AND COMPOSITION WITH AMINO ACIDS AND PPAR ACTIVATING FATTY ACIDS | June 2019 | December 2024 | Abandon | 60 | 5 | 0 | Yes | No |
| 16469128 | ADJUVANTS FOR AGROCHEMICAL FORMULATIONS | June 2019 | June 2025 | Allow | 60 | 8 | 0 | Yes | Yes |
| 16468592 | ADJUVANTS | June 2019 | July 2024 | Abandon | 60 | 2 | 0 | No | Yes |
| 16467097 | USE OF INSECTICIDES FOR CONTROLLING WIREWORMS | June 2019 | January 2022 | Abandon | 31 | 2 | 1 | Yes | No |
| 16465747 | HETEROCYCLIC COMPOUND AND HARMFUL ARTHROPODS CONTROL AGENT COMPRISING THE SAME | May 2019 | December 2022 | Allow | 43 | 1 | 1 | No | No |
| 16427505 | DRUG DELIVERY ARTICLES FOR GRAM-LEVEL DOSING | May 2019 | April 2024 | Abandon | 59 | 3 | 0 | No | No |
| 16423400 | AQUEOUS HERBICIDAL INTERMIXTURES | May 2019 | June 2024 | Allow | 60 | 5 | 1 | Yes | No |
| 16417096 | Clear or Translucent Composition | May 2019 | May 2022 | Abandon | 36 | 3 | 0 | No | No |
| 16336655 | PARTICULATE SUBSTANCE MIXTURE, PREFERABLY FOR USE IN THE PROPHYLAXIS AND/OR TREATMENT OF A RESPIRATORY DISORDER | March 2019 | July 2021 | Abandon | 28 | 1 | 0 | No | No |
| 16362780 | PLANT GROWTH REGULATOR OF ELEVATING ANTI-STRESS ABILITY AND USE THEREOF | March 2019 | October 2023 | Allow | 54 | 4 | 1 | Yes | No |
| 16361531 | AQUEOUS NEMATICIDAL COMPOSITIONS CONTAINING DISPERSANTS TO INHIBIT CRYSTAL GROWTH | March 2019 | September 2022 | Abandon | 42 | 3 | 1 | No | No |
| 16334136 | PHARMACEUTICAL COMPOSITION | March 2019 | June 2024 | Abandon | 60 | 6 | 0 | No | Yes |
| 16329305 | METHOD OF CONTROLLING FUNGAL INFECTIONS IN PLANTS | February 2019 | July 2023 | Allow | 53 | 5 | 1 | Yes | No |
| 16283660 | Topical Compositions and Methods for Treatment of Diabetic Neuropathies | February 2019 | February 2025 | Allow | 60 | 6 | 1 | Yes | No |
| 16256784 | TRANSDERMAL PREPARATION | January 2019 | November 2020 | Abandon | 22 | 1 | 0 | No | No |
| 16239754 | PROCESSING COMPOSITION FOR CONTROLLING AQUATIC WEEDS | January 2019 | April 2021 | Abandon | 28 | 0 | 1 | No | No |
| 16215455 | Compounds, Compositions, and Methods for Altering Insect and Organism Behavior | December 2018 | August 2023 | Allow | 56 | 5 | 1 | Yes | No |
| 16308664 | METHOD AND COSMETIC COMPOSITION FOR ENHANCED TRANSDERMAL DELIVERY OF ALKYL SUBSTITUTED RESORCINOL | December 2018 | October 2022 | Abandon | 46 | 5 | 1 | Yes | No |
| 16307423 | FUNGICIDAL COMPOSITION | December 2018 | August 2021 | Allow | 33 | 2 | 0 | Yes | No |
| 16306476 | SEQUENTIAL CLICK REACTIONS FOR THE SYNTHESIS AND FUNCTIONALIZATION OF HYDROGEL MICROSPHERES AND SUBSTRATES | November 2018 | April 2021 | Abandon | 28 | 1 | 1 | No | No |
| 16190260 | METHOD OF PREVENTING MICROBIAL DECAY AND BREAKDOWN OF COSMETIC COMPOSITIONS | November 2018 | October 2022 | Abandon | 47 | 3 | 1 | No | No |
| 16181970 | COMPOSITION AND METHOD FOR AIDING SLEEP | November 2018 | April 2022 | Abandon | 41 | 3 | 0 | No | No |
| 16095221 | Triple Negative Breast Cancer Treatment Method | October 2018 | November 2023 | Abandon | 60 | 4 | 1 | Yes | No |
| 16093474 | MEDICAL DEVICE COMPRISING GRAPHENE COATING | October 2018 | December 2024 | Abandon | 60 | 5 | 1 | No | No |
| 16155178 | METHODS AND COMPOSITIONS FOR CONTROLLING UNDESIRED VEGETATION SUCH AS INVASIVE ANNUAL GRASSES | October 2018 | November 2023 | Abandon | 60 | 4 | 0 | No | No |
| 16084526 | CORE-SHELL PLASMONIC NANOGAPPED NANOSTRUCTURED MATERIAL | September 2018 | April 2022 | Abandon | 43 | 4 | 1 | No | No |
| 16053623 | METHOD OF ENHANCING THE BIODISTRIBUTION AND TISSUE TARGETING PROPERTIES OF THERAPEUTIC CECO2 PARTICLES VIA NANO-ENCAPSULATION AND COATING | August 2018 | February 2021 | Abandon | 31 | 0 | 1 | No | No |
| 16071710 | OROMUCOSAL NANOFIBER CARRIERS FOR THERAPEUTIC TREATMENT | July 2018 | September 2024 | Allow | 60 | 6 | 1 | Yes | No |
| 16039172 | Foundation with controllable color change | July 2018 | November 2021 | Abandon | 40 | 2 | 1 | No | No |
| 16067820 | POLYVINYL ALCOHOL/SODIUM ALGINATE/HYDROXYAPATITE COMPOSITE FIBROUS MEMBRANE, AND PREPARATION METHOD AND APPLICATION THEREOF | July 2018 | August 2023 | Allow | 60 | 4 | 1 | Yes | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner SAEED, ALI S.
With a 33.3% reversal rate, the PTAB reverses the examiner's rejections in a meaningful percentage of cases. This reversal rate is below the USPTO average, indicating that appeals face more challenges here than typical.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 16.7% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.
⚠ Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.
⚠ Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.
Examiner SAEED, ALI S works in Art Unit 1616 and has examined 111 patent applications in our dataset. With an allowance rate of 28.8%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 42 months.
Examiner SAEED, ALI S's allowance rate of 28.8% places them in the 2% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by SAEED, ALI S receive 2.83 office actions before reaching final disposition. This places the examiner in the 92% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.
The median time to disposition (half-life) for applications examined by SAEED, ALI S is 42 months. This places the examiner in the 4% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +44.0% benefit to allowance rate for applications examined by SAEED, ALI S. This interview benefit is in the 91% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
When applicants file an RCE with this examiner, 12.3% of applications are subsequently allowed. This success rate is in the 3% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.
This examiner enters after-final amendments leading to allowance in 8.2% of cases where such amendments are filed. This entry rate is in the 4% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.
When applicants request a pre-appeal conference (PAC) with this examiner, 0.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 0% percentile among all examiners. Note: Pre-appeal conferences show limited success with this examiner compared to others. While still worth considering, be prepared to proceed with a full appeal brief if the PAC does not result in favorable action.
This examiner withdraws rejections or reopens prosecution in 50.0% of appeals filed. This is in the 11% percentile among all examiners. Strategic Insight: This examiner rarely withdraws rejections during the appeal process compared to other examiners. If you file an appeal, be prepared to fully prosecute it to a PTAB decision. Per MPEP § 1207, the examiner will prepare an Examiner's Answer maintaining the rejections.
When applicants file petitions regarding this examiner's actions, 85.7% are granted (fully or in part). This grant rate is in the 94% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 0% percentile). This examiner rarely makes examiner's amendments compared to other examiners. You should expect to make all necessary claim amendments yourself through formal amendment practice.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 0% percentile). This examiner rarely issues Quayle actions compared to other examiners. Allowances typically come directly without a separate action for formal matters.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.